ePrivacy and GPDR Cookie Consent by TermsFeed Generator

FEBUXOSTAT BAUSCH

80MG TBL FLM 14

SÚKL code 0242782
Name of the product FEBUXOSTAT BAUSCH
_MA_MEDICATION_DETAIL_INFO_MED_NAME i FEBUXOSTAT BAUSCH
Supplement 80MG TBL FLM 14
Strenght 80MG
Pharmaceutical form Film-coated tablet
Package 14
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance FEBUXOSTAT (FEBUXOSTATUM)
ATC group M04AA03
ATC group name FEBUXOSTAT

Marketing authorisation information

Registration Number 29/ 232/19-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 11. 2022
MA Holder Bausch Health Ireland Limited, Dublin
MA Holder country IRSKO
Actual MA holder Laboratorios Liconsa, S.A., Madrid
Actual MA holder country ŠPANĚLSKO

Back to list